Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-24-043585
Filing Date
2024-11-05
Accepted
2024-11-04 20:22:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 25484
2 formdefa14a_001.jpg GRAPHIC 482818
3 formdefa14a_002.jpg GRAPHIC 504004
  Complete submission text file 0001493152-24-043585.txt   1385847
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39717 | Film No.: 241425273
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)